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Mediterranean spotted fever (MSF) is a poten-
tially life-threatening zoonosis caused by Rickett-
sia conorii and transmitted by the brown dog tick
Rhipicephalus sanguineus [1]. Although MSF is one
of the oldest recognised rickettsioses, there have
been few reports about this rickettsiosis in North
Africa [1,2]. The present work on MSF cases
occurring in children is a subset of a larger study
conducted within all age categories.
PATIENTS AND METHODS
Patients younger than 15 years old who were seen at the Oran
Teaching Hospital in 2004–2005 with suspicion of rickettsioses
were prospectively included in this study. Informed consent
was obtained from all parents. For each child, the study
involved obtaining an acute-phase serum sample within
2 weeks of the onset of the symptoms and, when possible, a
convalescent-phase serum sample. IgG and IgM antibody
titres were estimated by an immunoﬂuorescence (IF) assay,
using 10 rickettsial antigens [2].When cross-reactions were
noted between several rickettsial antigens, Western blotting
and cross-adsorption studies were used to complement the IF
assay [2].
RESULTS
A total of 36 children were included in the study.
Most of them (75%) were taken to healthcare
providers before being seen at the Oran Univer-
sity Hospital. During a previous consultation they
were prescribed a ﬁrst-line antibiotics regimen, in
particular amoxicillin (56%) or amoxicillin-cla-
vulanate (22%); a few of them also received
penicillin G, erythromycin, spiramycin or cotrim-
oxazole.
A total of 24 cases were diagnosed as MSF.
Most (16 children) of them were encountered in
July (seven cases) and August (nine cases). The
median age was 4.5 years old (15 days to 14 years
old). A history of tick-bite was given in nine
(37.5%) cases. Contact with dogs was reported in
20 (83.3%) cases. Patients were seen at the
hospital after a median of 6 days (range 3–
10 days) of fever.
All children but one had fever (Table 1). A rash
was observed in all the children but one. It was
maculopapular and included the palms and soles
in 23 (92%) of the cases. One child had a petechial
rash. An inoculation eschar was observed in 20
(83.3%) children. In the majority (16 ⁄ 20) of the
cases it was localised in the cephalic region (retro-
auricular, the lobule of the ear, scalp). For four
other children, it was respectively localized on the
trunk, on the buttocks, in the inguinal area, and
between two toes. Eighteen patients (90%) pre-
sented with a single eschar, while two patients
presented with two eschars. Two children pre-
sented with seizure and were considered as a
severe form of MSF. Leucopenia was found in
eight cases (33.3%), leucocytosis in ﬁve (20%),
thrombocytopenia in four cases (16.6%) and
anaemia in 16 cases (66.6%).
Intravenous chloramphenicol was used as a
ﬁrst-line drug in eight children who presented
with vomiting. It was switched to oral josamycine
(macrolid, ﬁve cases), doxycycline (two cases) or
thiophenicol (one case). The 13 other children
received josamycine as a ﬁrst-line oral regimen.
DISCUSSION
We report here the largest prospective study
conducted on MSF in children in North Africa.
Although other spotted fever group rickettsioses
exist in Algeria [1], our cases have been conﬁrmed
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to be caused by R. conorii using immunoﬂuores-
cence methods completed by Western blot and
cross-absorption studies. Cases were encountered
in the summer, a classic pattern for MSF [1],
because Rh. sanguineus ticks are highly active and
more aggressive during the warmest months. Of
interest, two children presented with two eschars.
This is quite unusual in MSF, for which the
typical inoculation eschar at the tick-bite site is
usually unique [1,2]. However, particular climatic
circumstances, including higher temperature, that
were reported in Oran in recent years, may have
led to an increased proclivity of ticks to bite
humans (Parola et al., unpublished).
Although 62.5% of the children in the present
series were hospitalised, only two (those with
seizures) were considered to have a severe form.
During the same period in Oran, cases were
particularly severe in adults; 49% of 167 patients
diagnosed with MSF were hospitalised with a
severe form [2]. Therefore, cases of MSF seem to
be milder in children than in adults. Also, in
adults, the eschar is most often observed on the
trunk and legs [2]. Herein, the eschar is frequently
localised on the cephalic area, even in babies who
were not of walking age.
When they initially sought medical care, chil-
dren were prescribed drugs that were ineffective
to treat rickettsioses. It should be remembered
that doxycycline remains the treatment of choice
for all patients, including young children with
life-threatening rickettsioses [1]. The risk of dental
staining by doxycycline is negligible when a
single, relatively short course of therapy is
administered. Chloramphenicol continues to be
used as the empirical parenteral treatment of
severe cases if it is the sole available drug or in
children presenting with vomiting and lack of
intravenous doxycycline. Josamycin can be used
in children, but newer macrolides are also of
interest, particularly azithromycin [1].
MSF seems to be still misdiagnosed in children
as other eruptive febrile diseases. The conse-
quences of this include delays in appropriate
therapy and a risk of a severe form and even a
fatal outcome.
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Table 1. Clinical ﬁndings in 24 children with conﬁrmed
Mediterranean spotted fever (MSF) in Oran, Algeria, in
2004–2005, compared with three other published studies
from France, Sicily and Spain
MSF
Present study [3] [4] [5]
Clinical manifestations n = 24a (%) n = 41 (%) n = 415b (%) n = 130c (%)
Fever 23 (96) 41 (100) 386 (93) 130 (100)
Moderate 14 (58)
High 9 (38)
Rash 23 (96) 41 (100) 392 (95) 127 (98)
Eschar (Tache noire) 20 (83) 33 (80) 263 (63.4) 113 (87)
Unique 18 257
Multiple 2 6
Local lymphoadenopathy 12 (50) 214 (51.6) 79 (61)
Headache 9 (38) 6 (15) 122 (29) 82 (63)
Arthralgia ⁄myalgia 10 (42) 4 (10) 158 (38)
Diarrhea 4 (17) 4 (10)
Vomiting 3 (13) 2 (5) 37 (28)d
Splenomegaly 5 (20) 9 (22) 10 (8)
Hepatomegaly 2 (8) 3 (7.5) 21 (16)
Seizures 2 (8) 3 (7.5)
Meningism 4 (17) 8 (20) 3 (0.7)
Coma 0 0 0 0
Cough 2 (8) 2 (5) 2 (2)
Epistaxis 1 (4)
aCases deﬁnitely conﬁrmed to be caused by R. conorii, using immunoﬂuoresence
with a panel of rickettsial antigens, completed by Western blot and cross-absorption
studies.
bTwo hundred and thirty-two cases were conﬁrmed by IF serology, using R. conorii
antigen only.
cImmunoﬂuorescence to R. conorii was positive in 75% of the cases.
dNausea or vomiting.
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